Menu
2023 Session

Budget Amendments - HB1400 (Committee Approved)

View Budget Item
View Budget Item amendments

Authorization for Investment in Bioscience Research and Development Projects (language only)

Item 127 #1h

Item 127 #1h

Commerce and Trade
Virginia Innovation Partnership Authority

Language

Page 133, after line 9, insert:

"9. Notwithstanding the provisions of Paragraph K.9. of Chapter 56 of the 2020 General Assembly, Special Session I, the Virginia Biosciences Health Research Corporation may invest remaining nongeneral funds authorized in Chapter 56 for the research and development of therapeutic drug treatments for COVID-19 in bioscience research and commercialization projects."



Explanation

(This amendment authorizes the Virginia Biosciences Health Research Corporation to invest an estimated $2.4 million originally provided for investment in research and development of therapeutic drug treatments for COVID-19 in biosciences research, development, and commercialization projects. A project funded under the COVID-19 therapeutic drug treatment program was canceled and funding remains uncommitted. A companion amendment transfers $1.0 million of these funds authorized by the 2020 General Assembly, Special Session I to the general fund to offset investments in research and development projects in the agriculture technology industry.)